Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Holsapple

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Human & Experimental Toxicology|December 3, 2002
Developmental immunotoxicology and risk assessment: a workshop summaryM P Holsapple
Toxicology and Applied Pharmacology|October 1, 1993
Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDDS C Wood, M P Holsapple
Toxicology|July 1, 1990
Role of metabolism in dimethylnitrosamine-induced immunosuppression: a reviewH G Haggerty, M P Holsapple
Cancer Research|August 1, 1984
Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not by the noncarcinogenic congener benzo(e)pyreneK L White, M P Holsapple
Immunopharmacology|November 1, 1988
Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyteR K Dooley, M P Holsapple
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1993
Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytesS C Wood, M P Holsapple
Immunopharmacology|May 1, 1991
Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activationD L Morris, M P Holsapple
Toxicology and Applied Pharmacology|April 1, 1994
Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxinJ G Karras, M P Holsapple
Experimental and Clinical Immunogenetics|January 1, 1994
Mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced disruption of B-lymphocyte signaling in the mouse: a current perspectiveJ G Karras, M P Holsapple
Immunopharmacology|November 1, 1992
A functional characterization of macrophage alterations in casein-treated B6C3F1 miceN E Kaminski, M P Holsapple
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Human & Experimental Toxicology|December 3, 2002
Developmental immunotoxicology and risk assessment: a workshop summaryM P Holsapple
Toxicology and Applied Pharmacology|October 1, 1993
Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDDS C Wood, M P Holsapple
Toxicology|July 1, 1990
Role of metabolism in dimethylnitrosamine-induced immunosuppression: a reviewH G Haggerty, M P Holsapple
Cancer Research|August 1, 1984
Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not by the noncarcinogenic congener benzo(e)pyreneK L White, M P Holsapple
Immunopharmacology|November 1, 1988
Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyteR K Dooley, M P Holsapple
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1993
Effects of 7,12-dimethylbenz[a]anthracene on the superantigen toxic shock syndrome toxin (TSST-1)-induced proliferation and antibody secretion by human lymphocytesS C Wood, M P Holsapple
Immunopharmacology|May 1, 1991
Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activationD L Morris, M P Holsapple
Toxicology and Applied Pharmacology|April 1, 1994
Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxinJ G Karras, M P Holsapple
Experimental and Clinical Immunogenetics|January 1, 1994
Mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced disruption of B-lymphocyte signaling in the mouse: a current perspectiveJ G Karras, M P Holsapple
Immunopharmacology|November 1, 1992
A functional characterization of macrophage alterations in casein-treated B6C3F1 miceN E Kaminski, M P Holsapple
Pageof 10